Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucoseinfluxinduced catenin activation
Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation
More From BioPortfolio on "Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation"